TGTX logo

TG Therapeutics (TGTX) Working Capital

Annual Working Capital

$264.22 M
+$149.15 M+129.61%

31 December 2023

TGTX Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$448.95 M
+$168.47 M+60.06%

30 September 2024

TGTX Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TGTX Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+129.6%+71.7%
3 y3 years-49.6%+58.0%
5 y5 years+557.6%+10000.0%

TGTX Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-49.6%+129.6%at high+290.1%
5 y5 years-49.6%+557.6%-14.3%>+9999.0%
alltimeall time-49.6%>+9999.0%-14.3%+9230.3%

TG Therapeutics Working Capital History

DateAnnualQuarterly
Sept 2024
-
$448.95 M(+60.1%)
June 2024
-
$280.49 M(+7.5%)
Mar 2024
-
$260.90 M(-1.3%)
Dec 2023
$264.22 M(+129.6%)
$264.22 M(+1.1%)
Sept 2023
-
$261.44 M(+92.4%)
June 2023
-
$135.91 M(+11.7%)
Mar 2023
-
$121.71 M(+5.8%)
Dec 2022
$115.07 M(-56.7%)
$115.07 M(-21.4%)
Sept 2022
-
$146.47 M(-8.0%)
June 2022
-
$159.23 M(-15.1%)
Mar 2022
-
$187.56 M(-29.4%)
Dec 2021
$265.58 M(-49.3%)
$265.58 M(-6.5%)
Sept 2021
-
$284.12 M(-22.7%)
June 2021
-
$367.52 M(-16.9%)
Mar 2021
-
$442.52 M(-15.6%)
Dec 2020
$524.19 M(+710.2%)
$524.19 M(+187.0%)
Sept 2020
-
$182.66 M(-14.4%)
June 2020
-
$213.40 M(+757.1%)
Mar 2020
-
$24.90 M(-61.5%)
Dec 2019
$64.70 M(+61.0%)
$64.70 M(>+9900.0%)
Sept 2019
-
$158.00 K(-99.6%)
June 2019
-
$38.47 M(-12.8%)
Mar 2019
-
$44.12 M(+9.8%)
Dec 2018
$40.18 M(-38.5%)
$40.18 M(-42.2%)
Sept 2018
-
$69.50 M(-29.9%)
June 2018
-
$99.10 M(+18.5%)
Mar 2018
-
$83.61 M(+27.9%)
Dec 2017
$65.36 M(+92.3%)
$65.36 M(-16.1%)
Sept 2017
-
$77.87 M(+2.1%)
June 2017
-
$76.29 M(-23.1%)
Mar 2017
-
$99.24 M(+192.0%)
Dec 2016
$33.99 M(-55.5%)
$33.99 M(-37.6%)
Sept 2016
-
$54.45 M(-1.8%)
June 2016
-
$55.43 M(-10.1%)
Mar 2016
-
$61.68 M(-19.2%)
Dec 2015
$76.34 M(-4.7%)
$76.34 M(-19.7%)
Sept 2015
-
$95.04 M(+0.6%)
June 2015
-
$94.52 M(-11.0%)
Mar 2015
-
$106.19 M(+32.6%)
Dec 2014
$80.09 M(+122.6%)
$80.09 M(+18.2%)
Sept 2014
-
$67.76 M(+45.2%)
June 2014
-
$46.68 M(-14.0%)
Mar 2014
-
$54.30 M(+50.9%)
Dec 2013
$35.99 M(+121.3%)
$35.99 M(-19.9%)
Sept 2013
-
$44.94 M(+319.8%)
June 2013
-
$10.70 M(-30.1%)
Mar 2013
-
$15.32 M(-5.8%)
Dec 2012
$16.26 M(+97.6%)
$16.26 M(+0.4%)
Sept 2012
-
$16.20 M(-10.5%)
June 2012
-
$18.11 M(-8.5%)
Mar 2012
-
$19.78 M(+140.4%)
Dec 2011
$8.23 M(-439.5%)
$8.23 M(-784.6%)
Sept 2011
-
-$1.20 M(-62.1%)
June 2011
-
-$3.17 M(+29.5%)
Mar 2011
-
-$2.45 M(+1.1%)
Dec 2010
-$2.42 M
-$2.42 M(-17.5%)
Sept 2010
-
-$2.94 M(-5.2%)
DateAnnualQuarterly
June 2010
-
-$3.10 M(-36.9%)
Mar 2010
-
-$4.92 M(+116.8%)
Dec 2009
-$2.27 M(+270.6%)
-$2.27 M(+67.0%)
Sept 2009
-
-$1.36 M(+6.8%)
June 2009
-
-$1.27 M(+551.1%)
Mar 2009
-
-$195.40 K(-68.1%)
Dec 2008
-$612.10 K(-39.2%)
-$612.10 K(-67.8%)
Sept 2008
-
-$1.90 M(+151.9%)
June 2008
-
-$755.20 K(+79.9%)
Mar 2008
-
-$419.80 K(-58.3%)
Dec 2007
-$1.01 M(-174.5%)
-$1.01 M(-326.8%)
Sept 2007
-
$443.70 K(-83.0%)
June 2007
-
$2.61 M(-62.7%)
Mar 2007
-
$7.00 M(+418.3%)
Dec 2006
$1.35 M(-85.6%)
$1.35 M(-64.0%)
Sept 2006
-
$3.75 M(-29.3%)
June 2006
-
$5.31 M(-22.5%)
Mar 2006
-
$6.86 M(-26.8%)
Dec 2005
$9.36 M(+119.6%)
$9.36 M(-15.6%)
Sept 2005
-
$11.09 M(+1053.2%)
June 2005
-
$961.70 K(-65.6%)
Mar 2005
-
$2.80 M(-34.4%)
Dec 2004
$4.26 M(-37.5%)
$4.26 M(-28.4%)
Sept 2004
-
$5.96 M(-28.0%)
June 2004
-
$8.27 M(-9.7%)
Mar 2004
-
$9.16 M(+34.2%)
Dec 2003
$6.82 M(+969.9%)
$6.82 M(-935.2%)
Sept 2003
-
-$817.20 K(+50.7%)
June 2003
-
-$542.10 K(-492.5%)
Mar 2003
-
$138.10 K(-78.4%)
Dec 2002
$637.90 K(-43.1%)
$637.90 K(-1471.8%)
Sept 2002
-
-$46.50 K(-108.9%)
June 2002
-
$524.30 K(+11.9%)
Mar 2002
-
$468.60 K(-58.2%)
Dec 2001
$1.12 M(+40.4%)
$1.12 M(-499.8%)
Sept 2001
-
-$280.60 K(-184.2%)
June 2001
-
$333.30 K(-81.8%)
Mar 2001
-
$1.83 M(+129.3%)
Dec 2000
$798.70 K(-75.8%)
$798.70 K(-53.4%)
Sept 2000
-
$1.71 M(-10.9%)
June 2000
-
$1.92 M(-35.4%)
Mar 2000
-
$2.98 M(-9.8%)
Dec 1999
$3.30 M(-41.1%)
$3.30 M(-13.2%)
Sept 1999
-
$3.80 M(-7.3%)
June 1999
-
$4.10 M(-12.8%)
Mar 1999
-
$4.70 M(-16.1%)
Dec 1998
$5.60 M(-30.9%)
$5.60 M(-17.6%)
Sept 1998
-
$6.80 M(-13.9%)
June 1998
-
$7.90 M(+14.5%)
Mar 1998
-
$6.90 M(-14.8%)
Dec 1997
$8.10 M(+305.0%)
$8.10 M(-15.6%)
Sept 1997
-
$9.60 M(+380.0%)
June 1997
-
$2.00 M(+66.7%)
Mar 1997
-
$1.20 M(-40.0%)
Dec 1996
$2.00 M
$2.00 M(-33.3%)
Sept 1996
-
$3.00 M(+25.0%)
June 1996
-
$2.40 M

FAQ

  • What is TG Therapeutics annual working capital?
  • What is the all time high annual working capital for TG Therapeutics?
  • What is TG Therapeutics annual working capital year-on-year change?
  • What is TG Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for TG Therapeutics?
  • What is TG Therapeutics quarterly working capital year-on-year change?

What is TG Therapeutics annual working capital?

The current annual working capital of TGTX is $264.22 M

What is the all time high annual working capital for TG Therapeutics?

TG Therapeutics all-time high annual working capital is $524.19 M

What is TG Therapeutics annual working capital year-on-year change?

Over the past year, TGTX annual working capital has changed by +$149.15 M (+129.61%)

What is TG Therapeutics quarterly working capital?

The current quarterly working capital of TGTX is $448.95 M

What is the all time high quarterly working capital for TG Therapeutics?

TG Therapeutics all-time high quarterly working capital is $524.19 M

What is TG Therapeutics quarterly working capital year-on-year change?

Over the past year, TGTX quarterly working capital has changed by +$187.52 M (+71.73%)